Skip to main content
. 2018 Apr 24;19(5):1268. doi: 10.3390/ijms19051268

Figure 2.

Figure 2

Glucose profile using a continuous glucose monitoring system (CGMS) before (a) and after (b) initiation of continuous subcutaneous mecasermin infusion via an insulin pump.